Ann: CannEpil Authorised to Commence Australian Sales, page-167

Hi @Pnh88, 

I’m sorry, having problems with replying to posts with this new format, it’s just not working on I phone .  To answer your question, I don’t know the formulation of CannEpil, & regarding patents.  I think this is a question for Roby & being price sensitive, I think we will hear soon enough.  I did put this query out to Brett  Mitchell & alerted him that the question of patents was being brought up on HC.  

I do know that the greater the cost for a company to develop a drug/medication & the cost of clinical trials prior to licensing it, the more expensive it will be for the general public to access prior to PBS, one has only to look at Cancer drugs & MABs, but some of these are given on compassionate grounds via Health Services at PBS costs to patients.  I’m not 100% sure how all this works, but it does involve drug committees & letters from specialists via Specialist access schemes & post clinical trials.

I am invested in a range of biotechs, MXC is my only Medical Cannabis Pharma (yes now we are a legit Pharma ).  One question investing in biotechs that is important is patents with newly developed drugs or repurposing of them & where they are globally.

To me Medical Cannabis is a different kettle of fish, although seed to product is all important.  It is also important to be able to replicate the same formulation again & again, so that patients can remain on a standardised treatment that is working for them & continues to do so.  Having said that, patenting IP & products may become important for MXC the more successful the product is, I really don’t know?  What I do know is when something is working, you stick with it & don’t change unless your medical consultant tells you to, & all formulations will be a little different.

I think the price point of MGC products will be of huge benefit to Australian Epilepsy sufferers.  We are looking at 1/4 cost for an adult $10000 compared to a young child that I am assuming would require a much lower dose on weight that their parents are paying $40000 (quoted in Nine news), so maybe MXC can help an awful lot once CannEpil Kids is approved in Australia.  IMO & GLTA.  It’s a big wait & see on all of this, but hugely positive.